This week we highlight the impact of emerging biopharma on the life sciences industry, a new method for delivering gene therapy, an innovative device to improve safety and sleep quality in infants, and a cutting-edge treatment for vision loss caused by age-related macular degeneration. Finally, we look at ... READ MORE >
medical device
5 things to know in life sciences: Week of July 25, 2022
This week we highlight a new enhanced COVID-19 vaccine trial and the spin out of another major health care business. We also look at a Food and Drug Administration clearance for the smallest blood clot removal device and a company that raised $192 million based on a heart-attack-predicting software ... READ MORE >
5 things to know in life sciences: Week of June 7
The U.S. Food and Drug Administration’s approval of the Alzheimer’s drug, aducanumab, ushered in both a likely blockbuster for developer Biogen and sparked a debate both within the biopharma industry and among health care providers. We also look at a major medical device acquisition, investment in ... READ MORE >